转移
癌症
肿瘤进展
肺癌
原发性肿瘤
转录因子
生物
癌症研究
腺癌
癌变
肿瘤发生
调解人
循环肿瘤细胞
医学
战斗或逃跑反应
综合应力响应
细胞应激反应
癌细胞
神经科学
代谢适应
肿瘤科
突变体
细胞
肺
生物信息学
癌
作者
Mitchell E. Fane,Daniel J. Zabransky
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2026-04-21
卷期号:: OF1-OF3
标识
DOI:10.1158/0008-5472.can-26-1612
摘要
Aging is a major risk factor for cancer incidence and mortality, but its effect on tumor evolution and metastatic progression remains incompletely understood. A recent study by Patel and colleagues published in Nature reveals a paradoxical role for aging in cancer biology: while aging constrains primary tumor growth, it simultaneously enhances metastatic spread. Using genetically engineered mouse models and patient-derived data, the authors demonstrate that aging epigenetically reprograms mutant KRAS-driven lung adenocarcinoma through activation of the integrated stress response (ISR). Central to this process is the transcription factor ATF4, which promotes epithelial plasticity and metabolic adaptations, thereby enabling metastasis. This work provides a mechanistic framework linking host aging to tumor cell state transitions that favor distant spread of cancer cells. Importantly, it challenges a long-held assumption that tumor aggressiveness is primarily reflected by primary tumor growth kinetics and properties, and instead, it highlights metastasis as a distinct, age-influenced evolutionary trajectory. The identification of ATF4-driven ISR signaling as a mediator of metastasis highlights new therapeutic vulnerabilities, such as an acquired dependence on glutamine, particularly for older patients who comprise the majority of lung cancer cases. More broadly, this study underscores the need to incorporate aging biology into cancer models and therapeutic strategies, redefining how we conceptualize tumor progression across the lifespan.
科研通智能强力驱动
Strongly Powered by AbleSci AI